Company Filing History:
Years Active: 2012
Title: Alan Waxman: Innovator in Cancer Diagnosis
Introduction
Alan Waxman is a notable inventor based in Manhattan Beach, California. He has made significant contributions to the field of cancer diagnosis through his innovative research and inventions. His work focuses on utilizing fructose-based compounds to improve diagnostic techniques for cancer detection.
Latest Patents
Alan Waxman holds a patent for the "Use of fructose-based compounds for the diagnosis of cancer." This invention relates to compositions and methods that utilize fructose and other monosaccharides for diagnosing cancer. Research has shown that cancer cells exhibit a higher level of fructose utilization compared to glucose. Furthermore, these cells preferentially use fructose for nucleic acid synthesis. Waxman's invention leverages these characteristics, providing fructose or fructose-based compositions for cancer diagnosis using imaging techniques such as positron emission tomography. He has 1 patent to his name.
Career Highlights
Alan Waxman is affiliated with Cedars-Sinai Medical Center, where he continues to advance his research in cancer diagnostics. His work has the potential to significantly impact the way cancer is diagnosed and treated, offering new avenues for early detection.
Collaborations
Some of his notable coworkers include Anthony P. Heaney and Hongxiang Hui. Their collaborative efforts contribute to the innovative research environment at Cedars-Sinai Medical Center.
Conclusion
Alan Waxman is a pioneering inventor whose work in cancer diagnosis through fructose-based compounds showcases the intersection of innovation and medical research. His contributions are vital in the ongoing fight against cancer, paving the way for improved diagnostic methods.